AllPeptides.eu - Advanced Peptide Research
    Stacks
    Anti_aging

    GHK-Cu + Epithalon (50mg + 10mg)

    Subcutaneous (SC)See per peptide50mg + 10mg

    Reviewed by the AllPeptides.eu Editorial Team·Last reviewed: 2026-06-16

    🇷🇺 Phase II

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Research-only — no FDA/EMA approval
    Educational information. Not medical advice or a recommendation for use.

    ⚠️ For informational/educational purposes only. Not medical advice. We do not sell any products. Self-treatment carries serious risks — consult a healthcare professional. Disclaimer

    Free Access

    How It Works

    **GHK-Cu** activates a large network of genes via cell signaling: it increases collagen (I, III), decorin, elastin, FGF, VEGF, TGF-β, SOD, and antioxidant enzymes, while suppressing NFκB, TNF-α, IL-6, and MMPs (metalloproteinases). **Epithalon** activates the transcription of hTERT (telomerase), which adds TTAGGG repeats to telomeres, increasing cellular division potential (Hayflick limit).

    Quick Start

    • GHK-Cu: 1–2 mg SC, 1x/day (morning)
    • Epithalon: 5 mg SC, 1x/day (evening) × 10–20 days
    • Cycle: 4–6 weeks, 2x/year
    • Storage: Refrigerator 2–8°C after reconstitution
    Detailed Protocol Data

    Dosing Table — GHK-Cu + Epithalon Stack

    Educational only

    Route: Subcutaneous (SC) | Frequency: See per peptide

    WeekDoseUnits (per injection)
    1–2
    1mg GHK-Cu daily / 5mg Epithalon daily
    5 Units (0.05 mL)
    3–4
    2mg GHK-Cu daily / 5mg Epithalon daily
    10 Units (0.10 mL)
    5–6
    2mg GHK-Cu daily / —
    10 Units (0.10 mL)

    GHK-Cu: daily in the morning. Epithalon: daily in the evening before sleep × 10–20 days. GHK-Cu can be continued after the Epithalon course is complete.

    Related compounds

    Reconstitution Steps

    Dilution Selection

    Peptides come in 3 mL, 5 mL or 10 mL vials. If your vial is smaller, the water amount adjusts automatically.

    GHK-Cu (50 mg)

    BAC Water2.5 mL
    Concentration20.00 mg/mL

    Epithalon (10 mg)

    BAC Water2 mL
    Concentration5.00 mg/mL

    ⚠️ Units change depending on BAC water — always verify before administration. Based on

    Bacteriostatic Water (BAC Water): GHK-Cu + Epithalon is hydrophilic and dissolves easily in BAC water (sterile water with 0.9% benzyl alcohol). Benzyl alcohol prevents bacterial growth, allowing multiple draws from the same vial.
    1. GHK-Cu (50 mg): Add 2.5 mL BAC water → 20 mg/mL.
    2. Epithalon (10 mg): Add 2.0 mL BAC water → 5 mg/mL.
    3. Swirl gently. Use separate syringes.

    Protocol Overview

    • GHK-Cu (glycyl-L-histidyl-L-lysine:copper) is a naturally occurring copper tripeptide in human plasma. It declines dramatically with age (200 ng/mL at 20 → 80 ng/mL at 60).
    • Epithalon (AEDG tetrapeptide) was developed by Khavinson. It activates hTERT gene expression.
    • The combination: tissue regeneration (GHK-Cu) + telomere lengthening (Epithalon) = multi-pathway anti-aging.

    Dosing Protocol

    • GHK-Cu: 1–2 mg SC, 1x/day, morning. Titration: 1mg wk.1–2, 2mg wk.3+.
    • Epithalon: 5 mg SC, 1x/day, evening before sleep × 10–20 days.
    • Cycle: 4–6 weeks, 2 times/year (every 6 months).
    • GHK-Cu can also be used topically (cream) concurrently.
    • Break between cycles: 6 months between cycles. Epithalon is administered only 2x/year.

    Washout & Cycle Restart

    When can I restart?

    6 months between cycles. Epithalon is administered only 2x/year.

    Minimum wait period: 24 weeks

    Storage Instructions

    • Lyophilized: −20 °C (12–24 months).
    • Reconstituted: 2–8 °C, use within 4 weeks.
    • GHK-Cu may change color (blue-green) — this is normal due to the copper.

    Important Notes

    • GHK-Cu regulates 4,000+ genes — upregulating antioxidants and downregulating inflammatory ones.
    • Epithalon does not increase cancer risk — it only acts on normal cells (Khavinson 2003).
    • Do not administer GHK-Cu with copper chelators.
    • Bloodwork: telomeres (TeloYears/Life Length) + free copper before/after.
    Clinical Analysis & Safety

    Potential Benefits & Side Effects

    Potential Benefits:

    • Collagen and elastin synthesis (skin/joints)
    • Telomere lengthening (biological age)
    • Potent antioxidant action (SOD, glutathione)
    • Anti-inflammatory action (NFκB suppression)
    • Accelerated wound healing
    • Circadian rhythm regulation (melatonin/Epithalon)

    Potential Side Effects:

    • GHK-Cu: blue-green discoloration at the injection site (transient)
    • Epithalon: rare local redness
    • GHK-Cu: rare mild nausea at high doses (>3mg)
    • No serious adverse events reported

    ⚠️ Serious Warnings & Long-Term Risks

    The following warnings are based on published literature, FDA labels, and post-marketing surveillance. They do not constitute medical advice. Consult a healthcare professional.

    🎗️ Cancer Markers
    🟡 Moderate / Theoretical

    Telomerase & oncogenesis — conflicting data

    Epithalon activates telomerase (hTERT). While it appeared anti-cancer in animal models, telomerase activation is considered a hallmark of cancer. No long-term human studies exist.

    📄 Bull Exp Biol Med 2003; Khavinson VK
    🎗️ Cancer Markers
    🟡 Moderate / Theoretical

    Angiogenesis & tissue remodeling

    GHK-Cu promotes angiogenesis, tissue regeneration, and increases collagen/elastin. Theoretical concern for enhancing existing tumors, though no clinical signal exists.

    📄 Life Sci 2012

    References

    1. GHK peptide as a natural modulator of multiple cellular pathways — Pickart L et al., BioMed Res Int, 2015.
      View Source
    2. Epithalon activates telomerase in human somatic cells — Khavinson VK et al., Bull Exp Biol Med, 2003.
      View Source
    3. GHK-Cu: a regenerative peptide — Pickart L, Margolina A., Int J Mol Sci, 2018.
      View Source

    Recommended Supplements

    Research Sources & Verified Data
    …
    Clinical Trials
    …
    PubMed Studies
    Research-only
    FDA Status
    0
    Regulatory Approvals
    Verified across ClinicalTrials.gov, PubMed & FDA

    External Sources & Regulatory Status

    Regulatory Approvals

    🇷🇺
    МЗ РФ
    Phase II

    Anti-ageing / Telomerase

    Phase II in Russia (Khavinson)

    No official regulatory source available yet — research peptide.

    Educational information. Not medical advice, and no efficacy claim is implied. Regulatory approval is not a use recommendation by AllPeptides.eu.

    Summary:
    0 Approvals
    0 PubMed
    0 Clinical Studies

    Continue Your Research

    Explore tools and guides related to this protocol.

    Educational contentRegularly reviewed & maintainedEvidence-based review

    Important Disclaimer

    The content of this website is provided exclusively for informational and educational purposes within the context of research literature.

    Read the full Disclaimer →

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu